Get Premium to unlock powerful stock data
NAS:CLNN (USA)  
Clene Inc logo

Clene Inc

$ 2.65 -0.07 (-2.57%) 11:08 PM EST
P/E:
11.61
P/B:
83.44
Market Cap:
$ 167.63M
Enterprise V:
$ 161.36M
Volume:
207.11K
Avg Vol (2M):
333.40K
Also Trade In:
Volume:
207.11K
Market Cap $:
167.63M
PE Ratio:
11.61
Avg Vol (2-Month):
333.40K
Enterprise Value $:
161.36M
PB Ratio:
83.44
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Clene Inc
NAICS : 541714 SIC : 2834
6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Description
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).
Name Current Vs Industry Vs History
Cash-To-Debt 1.41
Equity-to-Asset 0.04
Debt-to-Equity 12.8
Debt-to-EBITDA -1.26
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.71
Distress
Grey
Safe
Beneish M-Score -99999999.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 42.26
9-Day RSI 46.16
14-Day RSI 47.85
6-1 Month Momentum % -42.28
12-1 Month Momentum % -79.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.77
Quick Ratio 7.76
Cash Ratio 6.68
Days Inventory 837.91
Days Sales Outstanding 44.48
Days Payable 12919.41

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-10 Est.)

CLNN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CLNN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.54
EPS (TTM) ($) 0.23
Beta 0
Volatility % 64.46
14-Day RSI 47.85
14-Day ATR ($) 0.4567
20-Day SMA ($) 2.869
12-1 Month Momentum % -79.29
52-Week Range ($) 1.93 - 17.82
Shares Outstanding (Mil) 63.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clene Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More